Jack Nathan Medical First Quarter 2025 Earnings: CA$0.022 loss per share (vs CA$0.009 loss in 1Q 2024)

Jack Nathan Medical (CVE:JNH) First Quarter 2025 Results

Key Financial Results

• Revenue: CA$5.28m (up 25% from 1Q 2024).
• Net loss: CA$1.92m (loss widened by 143% from 1Q 2024).
• CA$0.022 loss per share (further deteriorated from CA$0.009 loss in 1Q 2024).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Jack Nathan Medical shares are down 25% from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 5 warning signs for Jack Nathan Medical that you need to be mindful of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com